Concepedia

Ingo H. Gorr

IH

Statistics

Publications

16

Citations

2.8K

H-Index

14

Active since

2001

Affiliations

Boehringer Ingelheim (Germany)(Current)

Roche (Switzerland)

Roche Pharma AG (Germany)

Max Planck Institute of Biochemistry

University of Applied Sciences Biberach

Ingo H. Gorr is an author at Boehringer Ingelheim (Germany) specializing in life sciences, molecular biology, and cell biology.

Publications per year

2001–2021

16

Publications

16

Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

Carola H. Ries, Michael A. Cannarile, Sabine Hoves et al. · Cancer Cell · 2014 · 1.4K citations

Medicine, Immunology, Oncology +16

Mobilization of Processed, Membrane-Tethered SPT23 Transcription Factor by CDC48UFD1/NPL4, a Ubiquitin-Selective Chaperone

Michael Rapé, Thorsten Hoppe, Ingo H. Gorr et al. · Cell · 2001 · 443 citations

Life Sciences, Biochemistry, Molecular Biology +15

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 283 citations · Full text

Life Sciences, Immunology, Oncology +17

Mutual Inhibition of Separase and Cdk1 by Two-Step Complex Formation

Ingo H. Gorr, Dominik Boos, Olaf Stemmann · Molecular Cell · 2005 · 206 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors

Julia Hupfeld, Ingo H. Gorr, Christian Schwald et al. · Biotechnology and Bioengineering · 2014 · 78 citations

Engineering, Bioengineering, Cell Biology +17

1–5 of 16